Tthe U.S. Food and Drug Administration (FDA) has granted approval to WAINUA™ (eplontersen), a pioneering therapy for hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN) in adults. This regulatory milestone is anchored in the compelling data from the...
Sirnaomics Ltd., along with its subsidiary RNAimmune, Inc., a leader in mRNA-based vaccine technology, has recently achieved a milestone in their quest to develop advanced therapeutics. The U.S. Food and Drug Administration (FDA) has given the green light for...